News 30.04.2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Aktuell 26.03.2024 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 03.11.2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 18.10.2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
Actualités 17.04.2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23.04.2024 10:15–12:10 Zürich Швейцария
News 23.04.2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
Actualités 03.11.2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
Aktuell 22.06.2023 MSD weiht neues Forschungslabor in Schachen ein MSD Merck Sharp & Dohme (MSD) hat am Standort Schachen ein neues Forschungslabor eingeweiht. Dafür hat MSD 20 Millionen Franken investiert. Künft...
News 26.03.2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
News 29.01.2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 22.06.2023 MSD opens new research laboratory in Schachen MSD Merck Sharp & Dohme (MSD) has opened a new research laboratory at its site in Schachen in the canton of Lucerne. MSD has invested 20 million ...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23.04.2024 10:15–12:10 Zürich Швейцария
News 19.12.2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News 14.02.2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Evento S-GE Fattori chiave di successo per fare affari in Giappone 23.04.2024 10:15–12:10 Zürich Швейцария
News 20.02.2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...